Systematic review evaluating cardiovascular events of the 5-alpha reductase inhibitor - Dutasteride.
about
Testosterone, dihydrotestosterone, and incident cardiovascular disease and mortality in the cardiovascular health study.Use of 5-alpha-reductase inhibitors did not increase the risk of cardiovascular diseases in patients with benign prostate hyperplasia: a five-year follow-up study.Long-term safety and efficacy of dutasteride in the treatment of male patients with androgenetic alopecia.Current drug therapy of patients with BPH-LUTS with the special emphasis on PDE5 inhibitors.5α-Reductase inhibitors increase acute coronary syndrome risk in patients with benign prostate hyperplasia.
P2860
Systematic review evaluating cardiovascular events of the 5-alpha reductase inhibitor - Dutasteride.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Systematic review evaluating c ...... ctase inhibitor - Dutasteride.
@en
type
label
Systematic review evaluating c ...... ctase inhibitor - Dutasteride.
@en
prefLabel
Systematic review evaluating c ...... ctase inhibitor - Dutasteride.
@en
P2093
P2860
P356
P1476
Systematic review evaluating c ...... ctase inhibitor - Dutasteride.
@en
P2093
P2860
P304
P356
10.1111/JCPT.12080
P50
P577
2013-07-01T00:00:00Z